2025
Am J Physiol Cell Physiol. 2025 Nov 1;329(5):C1498-C1510. doi: 10.1152/ajpcell.00230.2025. Epub 2025 Oct 3.
Cachexia progression differs among mouse models of metastatic triple-negative breast cancer
Centre for Muscle Research, Department of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia. Metastasis Research Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia. Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia. Department of Neurology, The University of Washington School of Medicine, Seattle, Washington, United States.
Service type: Stock strains
Abstract
Cancer-associated cachexia decreases the quality of life, reduces therapy response, and diminishes survival prospects. Effective cachexia countermeasures remain a significant unmet need. Research into cancer cachexia has made extensive use of models of colon, lung, and pancreatic cancers. However, although cachexia also affects people with metastatic breast cancer, the mechanisms underlying breast cancer-associated cachexia are relatively understudied. Thus, we sought to investigate orthotopic mouse models of metastatic breast cancer for the progression of cachexia, with a focus on muscle wasting given its role in the frailty that is a hallmark of the condition. Female Balb/c mice received an intramammary fat pad injection of 4T1.2 or EMT6.5 cells, and NOD.SCID.γ (NSG) mice received MDA-MB-231-HM (231-HM) cells, to induce primary breast tumors that were subsequently excised. The resultant metastatic burden after approximately 4 wk led to variable loss of muscle mass (tibialis anterior: EMT6.5: -17.1%, 231-HM: -13.5%, and 4T1.2: -9.5%) and fat mass (gonadal fat: EMT6.5: -75.1%, 231-HM: -62.5%, and 4T1.2: -30.2%). Muscle protein synthesis markers were decreased in EMT6.5 tumor-bearing mice. Distinct increases in the abundance of mRNA for E3-ubiquitin ligase and autophagy-related genes were observed between models. Neuromuscular junction perturbations were observed in EMT6.5 and 4T1.2 tumor-bearing mice. Neutrophilia was noted in the muscles of EMT6.5 tumor-bearing mice. The findings show that muscle mass and function are reduced in mouse models of metastatic breast cancer. Further study of these models could provide useful insights with which to better understand the diversity of cachexia progression across different cancer types.NEW & NOTEWORTHY Cancer-associated cachexia is a significant contributor to poor prognosis for many cancer patients. However, mechanisms underlying cachexia associated with breast cancer are relatively understudied. This project examined mouse models of metastatic triple-negative breast cancer and found that different models exhibited varying degrees of cachexia severity, which were associated with distinct effects upon markers of protein synthesis and breakdown. Further study of these models could help to better understand the diversity of cachexia across cancer types.
Keywords: breast cancer; cachexia; muscle; neuromuscular junction; neutrophil.
